Healthtech & Wellness VC Funds

Madrona Venture Group, founded in 1995 and based in Seattle, Washington, focuses on early-stage and seed investments, particularly in the Pacific Northwest. The firm is known for its commitment to long-term partnerships with entrepreneurs, supporting them through the entire lifecycle from idea inception to market success. Madrona has a strong presence in sectors such as AI, intelligent applications, cloud computing, and enterprise software​. Madrona's investment philosophy, "Day One for the Long Run," emphasizes sustained engagement and strategic support. This approach has contributed to the success of companies like Smartsheet and Rover. Smartsheet, for example, overcame significant challenges during the 2008 financial crisis with Madrona's support, eventually going public in 2018. The firm has made over 550 investments, including in prominent companies like Snowflake, Redfin, and Apptio. Recent investments include Tektonic AI and Vilya, reflecting Madrona's focus on emerging technologies and innovative startups​. Madrona's team includes experienced professionals like Matt McIlwain and Scott Jacobson, who bring deep industry expertise and a hands-on approach to working with portfolio companies. This strong partnership ethos and strategic guidance have positioned Madrona as a key player in the venture capital landscape.

Magic Fund is a venture capital firm based in Los Angeles, California, founded in 2017 by a group of successful entrepreneurs including Kwamena A., Matt Greenleaf, Adegoke Olubusi, and Temi Awogboro. The firm focuses on pre-seed and seed-stage investments, supporting innovative startups across various sectors such as healthcare, logistics, insurtech, and gaming. Notable investments from Magic Fund include Retool, a low-code platform for internal tools development which has achieved unicorn status. Other significant investments are Renda, a logistics startup based in Nigeria, and LunaJoy, a U.S.-based healthcare company. Magic Fund operates with a philosophy of "founders backing founders," leveraging their network and experience to provide both financial and strategic support to early-stage companies. The firm has made over 153 investments and has seen several successful exits, including companies like WorkClout and Askdata.

Magma Partners is a venture capital firm focused on early-stage investments in Latin America, founded in 2014 by Nathan Lustig and Francisco Saenz Rica. With headquarters in Santiago, Chile, and additional offices across Mexico, Colombia, Argentina, and the USA, Magma Partners specializes in backing technology-driven startups that address significant problems in the region. The firm has invested over $80 million in more than 125 startups, with a strong focus on sectors such as fintech, insurtech, proptech, and marketplaces. Notable investments include Kushki, Albo, Billpocket, and R5. Magma Partners aims to support founders from the pre-seed stage up to Series A, offering both capital and strategic guidance to help them scale their businesses effectively. Magma Partners emphasizes solving big problems in large markets, believing that successful founders are those who address significant challenges faced by Latin Americans. They also provide extensive support through their "Magma Memo" system, which allows entrepreneurs to pitch their ideas and receive personalized feedback directly from the investment team. The team at Magma Partners consists of experienced entrepreneurs and operators, ensuring that they bring practical knowledge and expertise to their portfolio companies. The firm's commitment to fostering innovation in Latin America is reflected in its diverse portfolio and the successful growth of its investments.

Magnet Ventures is a San Francisco-based venture capital firm founded in 2016 by Georgia Lu. The firm primarily focuses on early-stage investments across biotechnology, healthcare, artificial intelligence, and other innovative technology sectors. Magnet Ventures has gained recognition for its strategic investments in companies leveraging advanced technology to transform fields such as drug discovery, diagnostics, and robotics. The firm's investment strategy is characterized by close collaboration with founders, offering not just capital but also strategic guidance and operational support. Magnet Ventures has invested in companies like Flux Biosciences, Atom Bioworks, and CloudMinds Robotics, showcasing its interest in high-potential sectors where AI intersects with biotech. The firm has achieved notable exits, including the sale of CloudMinds Robotics, further solidifying its reputation as a valuable partner for tech-driven startups. Magnet Ventures is led by a small but experienced team, including partners based in the U.S. with deep backgrounds in science, technology, and business. The firm continues to expand its portfolio by focusing on companies that are poised to drive future innovations across a range of critical industries, making it a key player in the global tech investment space.

Magnetic Ventures is a Miami Beach-based venture capital firm founded in 2018 by Christine Aylward. The firm specializes in early-stage investments, primarily focusing on companies at the intersection of technology and life sciences. With a strong emphasis on AI, machine learning, and biotech, Magnetic Ventures backs founders who are developing transformative solutions in healthcare. Their investment portfolio includes cutting-edge companies like Deep Genomics, Spotlight Therapeutics, and Paradigm, which are revolutionizing areas like drug discovery, gene editing, and clinical research. Magnetic Ventures typically makes initial investments ranging from $1 million to $6 million, entering at seed or Series A stages. The firm is deeply involved in supporting its portfolio companies throughout their growth, leveraging its extensive experience in healthcare regulation and commercialization. Their geographical focus is North America and Europe, with offices in Miami, Boston, and Research Triangle Park​. This hands-on approach and a mission to advance patient care through technology have made Magnetic Ventures a key player in driving innovation across the healthcare landscape.

Magnify Ventures is an early-stage venture capital firm based in Santa Monica, California, focused on driving the digital transformation of the care economy. Founded by Julie Wroblewski and Joanna Drake, the firm emphasizes investments in technology solutions that improve how families live, work, and care for one another. In 2022, Magnify Ventures raised a $52 million debut fund, with Pivotal Ventures, founded by Melinda French Gates, as the anchor investor. The firm targets four main areas within the care economy: parenting and family life, future of work, household optimization, and aging and longevity. Through these focus areas, Magnify Ventures supports startups developing innovative solutions to challenges that are often overlooked by traditional venture capital, such as caregiving, family well-being, and efficient home management. The portfolio includes companies like Papa, a platform connecting families with caregivers, and MiSalud, a digital health service aimed at the Latino community. By providing both capital and strategic support, Magnify Ventures helps these companies scale, leveraging an extensive network of advisors and partnerships with organizations like AARP and UCSF Rosenman Institute. The firm’s mission aligns with a broader vision to create a sustainable and inclusive care system that benefits families and supports economic growth through technology.

Main Sequence Ventures, founded in 2017 and backed by Australia's national science agency CSIRO, is a venture capital firm that focuses on deep tech and frontier technologies. The firm is headquartered in Australia and aims to solve significant global challenges through its investments. Main Sequence has a unique "venture science" model, which starts by identifying big challenges and bringing together science, people, and investment to create and fund companies that can address these issues. Main Sequence Ventures has built a strong portfolio with notable companies such as Q-CTRL, which makes quantum technology useful; Gilmour Space, which focuses on efficient satellite launches; and Emesent, a leader in robotics and autonomy technology. Other significant investments include Myriota, which provides low-cost satellite connectivity, and V2food, which develops sustainable meat alternatives. The firm's second fund, which raised $250 million, focuses on areas such as decarbonization, healthcare, and space technology. This fund supports companies like Kasada, a cybersecurity firm stopping bot attacks, and RapidAIM, which offers biosecurity solutions for pest management. Main Sequence Ventures is dedicated to leveraging scientific discoveries to create impactful, high-growth companies that can address some of the world's most pressing challenges. Their strategic investment approach and strong support for portfolio companies highlight their commitment to driving innovation and technological advancement globally.

Mairs & Power Venture Capital, established in 2021, is a venture capital arm of the renowned investment firm Mairs & Power, Inc., based in Saint Paul, Minnesota. The fund focuses on early-stage and seed investments, specifically targeting high-potential companies within the Upper Midwest, including states like Minnesota, Wisconsin, Illinois, Iowa, and the Dakotas. This regional emphasis allows the firm to leverage its local expertise and network to support emerging businesses across various sectors. Mairs & Power Venture Capital's investment strategy concentrates on sectors such as software, business services, healthcare, fintech, and edtech. The firm seeks to partner with innovative companies that have strong growth potential, providing initial investments typically around $1 million, with the ability to scale up depending on company needs. This approach reflects the firm's commitment to fostering regional innovation and supporting startups through their crucial early growth phases. The venture arm is led by General Partner John Bergstrom, who brings extensive experience from previous roles in venture capital and investment management. By integrating the operational support and expertise of its nearly century-old parent company, Mairs & Power Venture Capital aims to build a robust portfolio of tech-driven startups that can thrive on both local and national stages. The firm remains actively engaged in scouting for new investment opportunities within its focus sectors, reinforcing its mission to enhance the entrepreneurial ecosystem in the Upper Midwest.

Majycc Capital is a prominent French venture capital firm that focuses on revolutionizing the healthcare sector through strategic investments in innovative startups. Established in 2022 through the merger of Majycc eSanté Invest and UI Investissement, the firm now manages over €700 million, primarily dedicated to eHealth, MedTech, and BioTech ventures. Majycc Capital is particularly active in the Series A and B funding stages, where it seeks out high-potential startups across France and Europe that are positioned to deliver transformative advancements in healthcare. The firm's investment strategy goes beyond financial support. Leveraging its deep connections within the healthcare ecosystem, Majycc Capital provides comprehensive strategic assistance to its portfolio companies. This includes guidance on navigating complex regulatory pathways, insights into market dynamics, and support in business development—key elements that are crucial for scaling healthcare innovations. Majycc’s extensive network within the healthcare industry, including partnerships with healthcare manufacturers and private clinic groups, further amplifies the growth potential of the startups it backs. Majycc Capital’s commitment to innovation is underscored by its regional presence, with 13 offices throughout France, ensuring that it remains closely involved with local economies and emerging companies. The firm’s dedicated team, led by experienced professionals, is deeply invested in the success of its portfolio companies, working tirelessly to ensure they achieve their full potential in the competitive healthcare market​.

Maki.vc is a seed-stage venture capital firm that partners with deep tech and brand-driven startups focused on challenging category norms. Founded in 2018, Maki.vc invests in early-stage companies from their inception to Series A, emphasizing scientific advancements and unique customer understanding. Maki.vc has a global mandate, with a strong presence in the Nordics. The firm’s portfolio includes companies across various sectors such as AI, quantum computing, and sustainability. Notable investments include IQM, a leader in quantum computing; Spinnova, which develops sustainable textiles; and Onego Bio, which creates animal-free egg protein using novel technology. The firm’s approach goes beyond providing capital. Maki.vc supports its portfolio companies through Maki House, a platform that offers strategic guidance and a network of experts to help startups scale and achieve long-term success. Their investment philosophy centers on future-proofing companies by integrating ESG principles into their operations from the start, ensuring sustainability and long-term profitability.

Mana Ventures is a San Francisco-based venture capital firm that focuses on early to growth-stage investments, primarily in technology-driven sectors. Founded in 2016, the firm has built a diverse portfolio that includes companies across AI, software, consumer tech, healthtech, and more. Mana Ventures aims to back startups that are redefining industries through innovation, providing not only capital but also strategic support to help them scale. The firm’s portfolio features high-profile companies like Unity Technologies, a leading platform for game development, and Monarch, which focuses on AI-powered autonomous tractors. Mana Ventures is also known for its investments in companies like Synctera, a fintech software suite, and Odeko, which offers solutions for coffee businesses. Their strategic approach involves partnering with entrepreneurs from early stages and guiding them through product development, market expansion, and subsequent funding rounds. Mana Ventures emphasizes a hands-on approach, often leveraging its extensive network of LPs, founders, and industry specialists to support its portfolio companies. This network is designed to provide value beyond funding, including access to strategic partnerships, recruitment, and revenue-driving opportunities. With a keen focus on innovation and scalable tech solutions, Mana Ventures continues to shape and support startups that have the potential to lead their industries.

Mandi Ventures is an early-stage venture capital fund based in São Paulo, Brazil, with additional offices in Brussels. The fund focuses on investing in disruptive technologies within the food, agriculture, and climate tech sectors. Mandi Ventures primarily targets startups involved in novel foods, biotech, life sciences, robotics, and precision farming, aiming to reshape how we produce and consume food. Their global investment reach includes startups across the Americas, Europe, and Israel. Mandi Ventures supports seed-stage companies, offering not just capital but also strategic business expertise to help startups commercialize their innovations. They focus on areas like supply chain logistics, wellness, sustainability, and SaaS platforms within the food and agriculture ecosystem. Notable investments include companies driving innovation in biotech and precision farming, ensuring that the fund stays at the forefront of transformative food technologies. With a strong network and industry connections, Mandi Ventures plays an active role in guiding its portfolio companies through their growth stages, from scaling operations to market expansion.

Mangrove Capital Partners is a dynamic venture capital firm known for its bold, patient approach and commitment to supporting innovative entrepreneurs globally. The firm, headquartered in Luxembourg, has a strong presence in Europe with offices in Berlin, Paris, Barcelona, and London, as well as in Tel Aviv, Israel. Mangrove has a proven track record of backing successful companies, having been early investors in five unicorns: Skype, Wix, WalkMe, K Health, and TBOL. Mangrove's investment strategy focuses on early-stage tech startups, often partnering with entrepreneurs even before their product launch. They are particularly interested in transformational ideas across various sectors, including fintech, e-commerce, and health tech. Some of their rising stars include Red Points, Adverity, and Flo Health. The firm is known for its hands-on support, offering not just capital but also strategic guidance and operational assistance. Mangrove's team, comprising experienced entrepreneurs and operators, works closely with startups to navigate the challenges of scaling and growth. This approach is reinforced by their reputation for being more than just investors—they are seen as anchor partners deeply involved in their portfolio companies' success.

Maniv Mobility, founded in 2015 by Michael Granoff, is a prominent venture capital firm headquartered in Tel Aviv and New York. The firm specializes in early-stage investments focusing on the automotive, transportation, energy, and logistics sectors. Maniv Mobility has a strong global presence with investments across five continents, emphasizing innovative mobility solutions and sustainability. Notable investments in Maniv Mobility's portfolio include Turo, a peer-to-peer car rental platform; Nauto, an AI-enabled driver monitoring system; and Hailo, which develops neural processors for edge AI applications. These companies are among the three unicorns in their portfolio. Maniv Mobility has also seen several successful exits, including Arbe Robotics, Otonomo, and Voyage81. The firm's investment strategy involves pre-seed, seed, and Series A/B funding, with check sizes ranging from $1 million to $5 million. Maniv Mobility collaborates with corporate partners from the automotive and transportation industries, leveraging their expertise and networks to support startups in scaling their operations. Key team members include Michael Granoff, the founder and managing partner, and Nate Jaret, a general partner, both of whom bring extensive experience in venture capital and mobility sectors. Maniv Mobility is committed to advancing cleaner, safer, and more efficient transportation technologies, making it a pivotal player in the future of global mobility.

Manta Ray Ventures is an early-stage venture capital firm based in London, founded by Sebastian Kulczyk. The firm focuses on backing mission-driven founders who aim to address significant global challenges using advanced technologies. Manta Ray Ventures provides flexible and patient capital, leveraging their resources and networks to support their portfolio companies. Their diverse portfolio includes notable investments such as Volocopter, a manufacturer of electric copters for urban mobility; Astranis, a developer of satellite-based communication services; and Bluu Biosciences, focused on food and agriculture technology. They also have investments in companies like Epic Games, the creator of the popular game Fortnite, and Juvena Therapeutics, which is involved in drug discovery and clinical trials. Manta Ray Ventures has achieved significant exits, including the acquisition of Frontier Car Group by OLX Group and the merger of Forge Platform. The firm has also seen one of its portfolio companies, Bridge, go public on the Tokyo Stock Exchange. Led by a team of experienced professionals, including Managing Partner Lawrence Barclay and Partner Leah von Siemens, Manta Ray Ventures is dedicated to fostering innovation and supporting the growth of transformative technologies across various industries.

Mantis VC, co-founded by The Chainsmokers, is a venture capital firm based in Santa Monica, California. Since its inception in 2019, the firm has focused on early-stage investments across various sectors, including fintech, consumer technology, and media/entertainment. Notable investments in their portfolio include Pipe, a financing platform for SaaS companies; MoonPay, a financial technology company building payments infrastructure for cryptocurrencies; and Public, a social investing app aimed at democratizing stock market access. Other significant investments include Jeeves, a fintech company focusing on expense management, and Superplastic, a global entertainment brand known for animated celebrities. Mantis VC has raised substantial capital to support its investment activities, with successful funding rounds that have secured over $110 million. The firm prides itself on leveraging social capital and extensive industry networks to support the growth of its portfolio companies.

March Capital, established in 2014 and based in Santa Monica, California, is a venture growth firm focused on next-generation technology companies. The firm emphasizes sectors such as enterprise AI, fintech, and commerce enablement, aiming to partner with visionary entrepreneurs and support their growth to market leadership. Notable investments in March Capital's portfolio include CrowdStrike, a leader in cybersecurity; BillDesk, India's premier payments network; and Canva, an online design platform. They have also invested in companies like ActionIQ, a customer data platform, and ASAPP, an AI software company automating customer service. March Capital has seen successful exits from companies such as CarTrade, an online automotive marketplace, and Forescout, a cybersecurity firm. The firm is known for its collaborative approach, working closely with portfolio companies to provide strategic guidance and leveraging their extensive network to drive growth and success. They focus on building concentrated portfolios and doubling down on high-potential investments, ensuring significant impact and returns. March Capital also hosts The Montgomery Summit, a premier technology conference that gathers leading entrepreneurs, investors, and corporate executives to foster relationships and catalyze growth for portfolio companies.

Marcy Venture Partners (MVP), co-founded in 2018 by Shawn "JAY-Z" Carter, Jay Brown, and Larry Marcus, is a venture capital firm based in San Francisco. The firm focuses on investing in consumer and culture-driven companies that emphasize sustainability, inclusivity, accessibility, empowerment, and health & wellness. MVP's approach involves partnering with innovative businesses that are led by exceptional management teams and have strong brand values, outstanding products, and clear growth trajectories​. The firm has raised significant capital, closing its second fund with $325 million, bringing total assets under management to around $600 million. MVP has made investments in companies such as Therabody, Savage X Fenty, and Wheels, demonstrating a keen interest in diverse and impactful sectors. MVP is renowned for its robust support network and hands-on involvement, providing not just capital but also strategic guidance and industry connections to help its portfolio companies scale effectively​.

MaRS Investment Accelerator Fund (MaRS IAF) is one of Canada’s leading early-stage venture capital firms, based in Toronto. Established in 2008, it focuses on providing seed and pre-seed funding to high-potential technology startups across several sectors, including cleantech, healthtech, deeptech, and enterprise software. Over the years, MaRS IAF has made more than 175 investments, helping build transformative companies that contribute to Ontario's growing tech ecosystem. The firm typically offers up to $500,000 in initial funding, with follow-on investments as startups grow. MaRS IAF emphasizes not just capital but also strategic support, leveraging its vast network of industry experts, academia, and entrepreneurs. Their portfolio includes innovative companies like Mindbridge, ACTO, and Nicoya, which have collectively attracted more than $1.7 billion in follow-on funding. The fund is deeply integrated with the broader MaRS Discovery District, one of North America’s largest urban innovation hubs, which provides additional resources and mentorship for startups. MaRS IAF has been instrumental in fostering the growth of Ontario’s innovation sector, creating thousands of jobs and supporting startups as they scale to compete on a global stage.

Martlet Capital is an early-stage venture capital firm based in Cambridge, UK, focused on deep technology and life sciences B2B startups. Since its inception in 2011, Martlet Capital has invested in over 70 companies, providing patient capital to high-growth potential ventures. Their portfolio spans sectors like artificial intelligence, digital health, personalized medicine, engineering, IoT, new materials, and quantum technologies. Notable investments include Echion Technologies, known for their superfast-charging lithium-ion batteries, and IESO Digital Health, which provides real-time cognitive behavioral therapy online. They have also invested in companies like Converge, developing wireless sensor networks for real-time construction monitoring, and Dogtooth Technologies, which creates autonomous robots for productivity enhancement. Martlet Capital typically leads funding rounds and supports its portfolio companies beyond capital with strategic guidance, network access, and operational expertise. Their successful exits include Arachnys, Audio Analytic, and Cambridge CMOS Sensors. Martlet Capital's team comprises experienced investors and entrepreneurs, who actively engage in nurturing startups from early commercialization stages to scaling. Their investment strategy focuses on fostering innovation and driving growth in the UK, particularly within the Cambridge tech ecosystem. For startups seeking investment, Martlet Capital looks for innovative solutions with scalable business models in deep tech and life sciences. They prioritize strong leadership teams and groundbreaking technologies that can make a significant impact on their respective industries.

Marubeni Corporation, founded in 1858 and incorporated in 1949, is a prominent Japanese general trading company headquartered in Tokyo. The company operates across numerous sectors including lifestyle, IT solutions, food, agriculture, chemicals, metals and mineral resources, energy, power, infrastructure projects, aerospace, shipping, finance, leasing, real estate, and industrial machinery. Marubeni is committed to sustainability and innovation, aiming to create solutions that foster positive societal impact while maintaining financial performance. This commitment is reflected in their investments and operations across diverse industries worldwide. The company's philosophy of "Fairness, Innovation, and Harmony" drives its vision for a sustainable and prosperous future. The company has a robust global network with over 4,300 employees and numerous subsidiaries and affiliates, highlighting its significant presence and influence in the international market. Marubeni's extensive operations and strategic investments underscore its role as a key player in global trading and investment.

MassMutual Ventures (MMV) is a global venture capital firm that invests in a range of sectors, including enterprise software, cybersecurity, financial technology, digital health, and climate technology. Founded in 2014 and based in Boston, MMV also has offices in London and Singapore. The firm manages over $1 billion in investment capital and focuses on accelerating the growth of its portfolio companies by providing capital, connections, and strategic advice. Notable investments by MMV include Prove, a leader in digital identity solutions; Daye, a gynecological health startup; and Griffin, a developer-friendly Banking as a Service platform. The firm's portfolio spans across various stages of investment, from seed to growth stage, with typical check sizes ranging from $100,000 to $5 million. In 2022, MMV launched a $100 million Climate Technology Fund to invest in early and growth-stage companies addressing climate change. This fund aims to support 15 to 20 companies developing solutions to mitigate, measure, and manage climate change impacts, further expanding MMV's commitment to sustainable innovation​. The team at MMV includes experienced investors, former entrepreneurs, and operators, such as Doug Russell, the Managing Partner and Head of MMV, and Ryan Collins, the Managing Partner for Europe and APAC. Their deep industry expertise and extensive network help portfolio companies scale and succeed in competitive markets.

MassVentures, established in 1978 as the Massachusetts Technology Development Corporation, is a venture capital firm dedicated to supporting early-stage technology startups in Massachusetts. With a mission to bridge the capital gap for startups, MassVentures has invested $91.9 million in 152 companies from its inception through June 2019. The firm focuses on diverse sectors including life sciences, robotics, and advanced manufacturing, and typically makes initial investments of $250,000 to $500,000. Notable investments include Battery Resourcers, Inkbit, and Pison. Additionally, MassVentures administers the Small Business Innovation Research Targeted Technologies (SBIR-TT) grant program, which has awarded $22.1 million to 79 companies since 2012. This program supports the commercialization of innovations emerging from academic research and small businesses, fostering technological advancement and job creation in the state. MassVentures is led by an 11-member board of directors, predominantly from the private sector, and operates with a small team based in Boston. The firm not only provides financial support but also strategic guidance and operational expertise to help startups scale successfully. Through its investments and grant programs, MassVentures plays a crucial role in the growth of Massachusetts' innovation ecosystem, aiming to enhance the state's economic development by nurturing high-potential startups.

Mastry Ventures, recently rebranded as Mosaic General Partnership, is a venture capital firm based in San Francisco, California. The firm was founded by Andre Iguodala and Rudy Cline-Thomas and focuses on early-stage investments in the technology and consumer sectors. Their portfolio includes investments in high-profile companies such as Datadog, Zoom, and Uber​. Mosaic General Partnership aims to support founders who are creating innovative and impactful solutions. The firm leverages a network that includes influential public and private company founders, seasoned operators, and prominent athletes and influencers to provide strategic guidance and support to their portfolio companies​.

Matchstick Ventures, founded in 2013 and based in Boulder, Colorado, and Minneapolis, Minnesota, focuses on early-stage investments, particularly at the seed stage. The firm targets high-growth technology companies in underserved startup ecosystems, especially in the Rockies and North. Their portfolio includes notable investments such as Upsie, which offers affordable and reliable warranties for electronic devices; StackHawk, which provides tools for developers to incorporate security testing into their applications; CometChat, which enables businesses to add voice, video, and chat capabilities to their apps and websites; and Inspectorio, which enhances transparency and efficiency in the global supply chain. Typically, Matchstick Ventures invests in seed and early-stage companies with initial check sizes ranging from $500,000 to $1.5 million. The firm is known for its hands-on approach, offering extensive support to its portfolio companies through strategic guidance, networking opportunities, and operational assistance. Led by partners Ryan Broshar and Natty Zola, Matchstick Ventures is deeply embedded in local startup communities, actively contributing to their growth and development through various initiatives and collaborations.

Material Impact, founded in 2015 by Adam Sharkawy and Carmichael Roberts, is a venture capital firm based in Boston, Massachusetts, that focuses on transforming material science innovations into impactful real-world applications. The firm is dedicated to addressing large-scale problems related to food, water, sustainable manufacturing, transportation, mobility, and healthcare through its investments in deep tech companies. Material Impact's portfolio includes notable companies such as DetraPel, Bloomer Tech, Folio Photonics, and Nohbo. These investments span a range of industries, including specialty chemicals, healthcare monitoring equipment, IT storage, and personal products. The firm’s hands-on approach to building companies involves working closely with founders to guide them through critical growth stages​. In 2023, Material Impact announced its $352 million Fund III, aimed at continuing its mission to support early-stage startups that leverage material science to solve pressing global challenges. This new fund allows Material Impact to take larger ownership stakes while maintaining its active role in company development. The firm's commitment to diversity and impact is reflected in its alignment with the United Nations Sustainable Development Goals and its diverse leadership team​. For entrepreneurs interested in partnering with Material Impact, the firm values innovations that have strong scientific foundations and the potential to address significant human needs. Material Impact provides not only capital but also strategic and operational support, often embedding its team members within portfolio companies to ensure their success.

Math Venture Partners, founded in 2014 and based in Chicago, Illinois, is an early to middle-stage venture capital firm that focuses on investing in digital and technical companies. The firm emphasizes supporting entrepreneurial teams with a strong focus on customer acquisition and operational efficiency, leveraging their extensive experience as operators who have built, scaled, and sold businesses valued at over $7 billion. The firm has a diverse portfolio across various sectors, including SaaS, marketplace businesses, and tech-enabled services. Notable investments include Acorns, a wealth-building platform; Built In, a national recruiting platform for technical and sales talent; Chowly, which helps restaurants manage their menus and connectivity to third-party tech; and NoRedInk, an e-learning platform that improves students' grammar and writing skills. Math Venture Partners is managed by seasoned investors and operators, including Managing Directors Mark Achler, Troy Henikoff, and Dana Wright. They have partnered with over 200 companies, focusing on providing both capital and strategic support to help them grow with greater certainty. Despite their success, the firm announced that they will not raise a third fund, citing the challenging fundraising environment and their commitment to fully supporting their current portfolio companies.

Matrix Partners is a powerhouse in early-stage venture capital, boasting over four decades of experience and $4 billion in assets under management. Their portfolio spans transformative startups like Canva, Afterpay, Oculus, and Hubspot, among 65+ IPOs and 110+ acquisitions. With offices in San Francisco and Boston, Matrix invests globally, focusing on the U.S., India, and China. Their sweet spot is in sectors like AI, fintech, digital health, and B2B SaaS. Matrix is known for its commitment to backing founders from seed through Series A, providing checks ranging from $100K to $1M. They emphasize patience, nurturing relationships with company builders and former founders, helping them scale effectively. While they often lead rounds, Matrix also co-invests, partnering with top VCs like Y Combinator and Andreessen Horowitz. Key team members include Pranay Desai and Paul Sherer in San Francisco, and they maintain a reputation for being hands-on, leveraging deep expertise across diverse tech-driven industries. Entrepreneurs seeking funding should approach Matrix with a clear vision for scalable innovation, as the firm is laser-focused on high-impact, technology-driven ventures.

Matterwave Ventures, established in early 2022 from the former btov Industrial Technologies team, focuses on investing in early-stage European industrial hardware and software companies. Headquartered in Munich, Germany, Matterwave aims to empower startups to become global leaders in the industrial sector. Their €130M Matterwave Industrial Technologies II fund backs 20-25 companies, with initial investments ranging from €1M-4M and up to €10M in follow-on rounds. Matterwave's investment strategy prioritizes automation, digitalization, and resource efficiency within industrial value chains. They target technologies in enterprise automation, frontier tech, production optimization, and sensor-powered solutions. Notable portfolio companies include TVARIT, which specializes in AI for sustainable manufacturing, and Orcan Energy, focusing on industrial heat capture. Led by a team with over 50 years of combined venture capital experience, Matterwave Ventures leverages deep industry knowledge and strong market connections to support its portfolio companies. The team includes experts with backgrounds in engineering, physics, and technology commercialization, ensuring they provide comprehensive strategic guidance. Matterwave Ventures emphasizes sustainability and resource efficiency, aligning their investments with the EU's Sustainable Finance Disclosure Regulation. This commitment reflects their broader goal of enhancing Europe's industrial competitiveness while addressing environmental challenges​.

Maven Ventures is a seed-stage venture capital firm specializing in consumer software startups. With a notable track record, Maven has backed major successes like Zoom, Cruise, and Epic!, achieving significant exits and IPOs. Founded in 2013, the firm has maintained a focused strategy, supporting around 50 high-potential startups with investments typically ranging from $750K to $1M. The firm is keenly interested in emerging consumer trends and technologies, investing in sectors like digital health, autonomous vehicles, fintech, and AI-driven solutions. Geographic focus primarily includes the United States, particularly Silicon Valley, but Maven also invests in global opportunities. Maven Ventures' strategy is highly selective, with a small team providing hands-on support to a concentrated portfolio. The team, led by seasoned investors like Jim Scheinman, focuses on building deep relationships with founders, offering critical guidance on marketing, product development, and go-to-market strategies. Recent investments include startups like Hello Heart, which provides mobile solutions for heart health, and Wildtype, a company pioneering lab-grown seafood. The firm has a proactive approach to diversity, supporting a range of women-led and minority-led startups. Maven Ventures prefers to be approached through a well-articulated pitch that demonstrates a strong market need and scalable solution. With a reputation for nurturing bold founders and transformative ideas, Maven Ventures remains a prominent player in the VC landscape, consistently driving innovation and impactful growth in the consumer tech sector​.

Maverick Ventures, established in 2015, is the venture capital arm of Maverick Capital, a multi-billion dollar investment firm. Based in San Francisco, Maverick Ventures focuses on early-stage and growth-stage investments, particularly in healthcare and technology sectors. The firm prides itself on combining the agility of a focused venture team with the extensive resources and reputation of a global investment firm. Maverick Ventures has built a diverse portfolio that includes notable companies such as Cityblock Health, Devoted Health, Collective Health, and Databricks. They typically support startups through seed to maturity stages, providing not just capital but also strategic guidance and operational support. The team at Maverick Ventures includes experienced investors like Lee Ainslie, who bring a wealth of expertise to their investments. The firm operates with an evergreen fund structure, allowing them to reinvest profits and continuously support their portfolio companies.

Maveron, a consumer-only venture capital firm, was founded in 1998 by Dan Levitan and Howard Schultz, the visionary behind Starbucks. The firm focuses on early-stage investments in transformative consumer brands. With a keen understanding of consumer behavior and market trends, Maveron has built a diverse portfolio that includes notable companies like Allbirds, Everlane, and Zulily. Maveron operates with a mission to back entrepreneurs who aim to change how people live, work, learn, play, eat, and stay well. Their investments span various consumer sectors such as health and wellness, e-commerce, and food innovation. Some of their prominent exits include eBay, Trupanion, and Potbelly Sandwich Works. The firm recently raised $225 million for its eighth fund, continuing its legacy of identifying and supporting early-stage consumer startups. Maveron's team, led by experienced partners like Dan Levitan and Jason Stoffer, brings deep industry knowledge and a commitment to fostering long-term partnerships with entrepreneurs.

Max Ventures, founded in 2013 by Ryan Darnell and Sophie Stenbeck, is a dynamic seed-stage venture capital firm based in New York. Notable for its early investments in companies like Boxed, ZoomCar, Button, and Drone Racing League, Max Ventures focuses on consumer tech and health-tech startups. The fund targets North American markets and emphasizes investing in founders with unique consumer insights and relentless drive. Max Ventures typically makes initial investments ranging from $750K to $1M, often leading the rounds. Their strategy involves a hands-on approach, leveraging their extensive network to support portfolio companies in achieving significant growth. The fund is particularly interested in startups within the fashion/beauty, food and beverage, internet and web services, real estate, and software industries. The team, including key figures like Managing Partner Matthew Weinberg, prides itself on its ability to identify and nurture innovative talent. Startups looking to approach Max Ventures should focus on demonstrating strong consumer insight and a clear execution plan. Recently, the firm has been active with investments like UnityAI in healthcare technology, showcasing their ongoing commitment to pioneering advancements in tech.

Maxfield Capital is a venture capital firm specializing in early-stage investments, focusing on IT and internet sectors. Established in 2013 by Alexander Turkot, the firm has a global presence with offices in New York, Tel Aviv, and Moscow. Maxfield Capital aims to bridge the gap between high-quality engineering and commercial execution, helping startups scale globally. The firm's investment focus includes sectors such as e-health, digital lending, data protection, mobility, e-education, marketplaces, and cloud computing. Maxfield Capital typically invests in companies that are beyond the seed stage, preferring those with more advanced development​. Alexander Turkot, the founder and managing partner, brings extensive experience from his background in IT, engineering, and project management, including significant roles at IBM and the Skolkovo project. Other key partners include Oleg Koujikov and Alexander Lazarev, who manage operations across various regions.

Maya Capital, founded in 2018 by Lara Lemann and Monica Saggioro, is a venture capital firm based in São Paulo, Brazil. The firm focuses on early-stage investments in Latin American startups, aiming to lead the first institutional funding rounds and provide hands-on support to its portfolio companies. Their approach includes assisting with hiring, go-to-market strategies, and fundraising efforts. Maya Capital's portfolio includes notable investments such as NotCo, a food tech company specializing in plant-based products, and Merama, an e-commerce platform aggregator. These investments have elevated both companies to unicorn status, showcasing Maya Capital's ability to identify and nurture high-potential startups. With the recent close of their second fund at $100 million, Maya Capital plans to invest in 25 to 30 new companies, with a significant portion reserved for follow-on funding. The firm aims to support the best founders in Latin America and expand their reach among Spanish-speaking entrepreneurs across the region. Their investment strategy balances a strong presence in Brazil with significant investments throughout other Latin American countries, such as Mexico, Colombia, and Chile. Maya Capital emphasizes long-term partnerships and being an integral part of their portfolio companies' journeys from early stages to successful scaling. This commitment is reflected in their proactive support and the extensive network they leverage to benefit the startups they invest in.

Mayfield is a renowned venture capital firm founded in 1969, with a focus on early-stage investments. The firm is based in Menlo Park, California, and has a strong presence in the U.S. and India. Mayfield has made significant contributions to the tech industry, backing over 852 companies, including notable names like Lyft, Couchbase, and Poshmark. Mayfield’s portfolio showcases a diverse range of sectors, emphasizing artificial intelligence, enterprise software, consumer tech, semiconductors, and human and planetary health. Some of their standout investments include Unstoppable Domains, Amagi, and BigPanda, which have grown into unicorns under their guidance. The firm has also successfully shepherded companies to IPO, such as Lyft and Couchbase, and facilitated numerous high-profile acquisitions. The firm operates with a "people-first" investment philosophy, aiming to partner with visionary entrepreneurs from inception through growth stages. They typically invest in Seed, Series A, and Series B rounds, providing not only capital but also strategic support and mentorship. Mayfield's investment team includes seasoned partners like Navin Chaddha and Ursheet Parikh, who bring extensive industry experience and a track record of successful exits. Mayfield's investment strategy involves close collaboration with founders, focusing on building enduring companies that can achieve market leadership. Founders looking to connect with Mayfield should highlight their innovative solutions and potential for significant impact, aligning with the firm’s mission to back transformative technologies.

MariaMazarine Ventures is a Chicago-based venture capital firm dedicated to addressing the global water crisis through technology. Founded in 2018, Mazarine exclusively invests in early-stage startups that are developing innovative solutions for managing water and wastewater-related risks across various industries. These sectors include agriculture, aquaculture, climate tech, and industrial applications, among others. The firm operates multiple funds, each with a unique focus. Fund II, for instance, targets companies with proven commercial traction—often nearing $1 million in annual sales—and intellectual property rooted in fields like chemistry, data science, and materials science. Mazarine typically leads seed and early Series A rounds, cutting checks between $25,000 and $500,000, and often continues to support its portfolio companies through follow-on investments. Mazarine’s investment strategy is centered on mitigating critical risks—such as public health, environmental protection, and business continuity—posed by water scarcity and quality issues. The firm’s approach extends beyond financial backing; it leverages a network of experienced operators and co-investors to provide strategic support, helping startups scale and achieve meaningful impact. The leadership team, including co-founders John Robinson, Pete Nassos, and Anders Hallsby, brings decades of experience in commercializing water and wastewater technologies. Mazarine’s rigorous focus on ESG (Environmental, Social, and Governance) metrics underscores its commitment to not only financial returns but also substantial environmental and social impact​. wll do on Thu

in 2001, MBVP primarily focuses on medical device startups, particularly those addressing musculoskeletal diseases. Notable investments include startups acquired by industry giants like Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now part of Stryker). MBVP's strategy emphasizes providing not just capital but also strategic direction, leveraging their deep industry connections and expertise. They typically invest at all stages of development, ensuring that startups have the support they need from inception through to exit. The firm is known for its active role in the Musculoskeletal New Ventures Conference, a testament to its leadership in the sector. The team is led by co-founder Gary Stevenson, whose background includes significant roles in healthcare investment banking, equity research, and general management at Abbott Laboratories. Gary's comprehensive experience and his educational background, including an MBA from Northwestern University's Kellogg School of Management, underscore the firm's robust leadership. MBVP prefers to be approached by startups with a clear, compelling value proposition in the life sciences sector. They are known for writing substantial checks and often lead investment rounds. Their involvement in over 50 startups highlights their active investment approach and commitment to advancing medical innovations​.

MBX Capital, established in 2015, is a venture capital firm headquartered in Claymont, Delaware. The firm specializes in early-stage investments within the healthcare and life sciences sectors, focusing on pre-seed, seed, and Series A rounds. MBX Capital has a robust portfolio that includes companies like Luna, Concert Health, Koneksa Health, Atlas Labs, and Buoy Health​. Notable recent investments by MBX Capital include Vivodyne, which raised $38 million in November 2023, and Macro Trials, which secured $6 million in June 2023. These investments underline the firm's commitment to advancing biotechnology and clinical trials​ (PitchBook)​. Additionally, MBX Capital led a $10.7 million Series A financing for Contraline, supporting the development of innovative medical technologies​​. The firm's co-founders, Gurdane Bhutani and Zeshan Muhammedi, lead a team that provides hands-on support to portfolio companies, leveraging their expertise and extensive network to drive growth and innovation​​. MBX Capital's strategic approach and active involvement make it a key player in the venture capital landscape for healthcare and life sciences startups.

MD Start is a unique medtech incubator and fund based in Paris, dedicated to transforming early-stage medical device ideas into commercially viable companies. Founded in 2010, it partners with leading institutions like Medtronic, Bpifrance, and Sofinnova Partners to support innovative concepts that are too early for traditional venture investment. MD Start’s approach is hands-on, focusing on developing, managing, and de-risking projects to attract later-stage investment. The incubator primarily targets groundbreaking European medtech innovations, working closely with physicians and researchers to evaluate over 1,400 ideas, resulting in the creation of 7 companies. With expertise spanning product development, regulatory strategy, and clinical validation, MD Start ensures rapid and capital-efficient progress from idea to market. The team is led by experienced industry veterans like Gérard Hascoët, Anne Osdoit, and Lukas Guenther, who are instrumental in the incubator's success. Their focus is on turning early concepts into disruptive technologies, particularly in therapeutic devices and surgical tools. MD Start’s unique model and strong industry backing make it a vital player in Europe’s medtech landscape.

Medevice Capital is a Paris-based venture capital firm founded in 2011 that specializes in investing in early-stage MedTech and e-health startups. The fund primarily targets innovative companies in the healthcare sector, with a focus on medical devices and diagnostic technologies. Medevice typically invests in rounds ranging from $1 million to $5 million, supporting startups at the seed and later stages​. Some notable portfolio companies include Pixyl, which develops AI-driven medical imaging solutions, and Emagina, focused on women's health with a connected device for perineum care. Medevice also invested in Dyameo, which is working on cancer detection devices​. The firm is led by Cécile Réal, the founder and CEO, and its team has a strong background in healthcare entrepreneurship and investment. Medevice remains active, making approximately two investments per year, particularly within the European market.

Medicxi is a premier European venture capital firm specializing in life sciences, with a focus on drug discovery and therapeutic development. Established in 2016 by the former life sciences team of Index Ventures, the firm has raised over €1 billion across various funds. Medicxi’s flagship funds, such as Medicxi III (€400 million), invest in both early and late-stage biopharma companies. Notable investments include Genmab, Micromet (acquired by Amgen), and Minerva Neurosciences. Medicxi's investment strategy is centered around its "asset-centric" approach, where the firm invests in companies with strong clinical proof-of-concept that address clear unmet medical needs. Their investments typically range between €10 million and €25 million, supporting companies through key phases like clinical development and regulatory approval​. The firm partners closely with major pharmaceutical players such as Novartis, Johnson & Johnson, and GlaxoSmithKline, which provides strategic backing for its portfolio companies​. Headquartered in London, Geneva, and Jersey, Medicxi has become a leading name in European biotech, with a strong emphasis on translating scientific innovation into commercially viable drugs. Their portfolio spans across the full healthcare continuum, from early discovery to late-stage clinical assets, giving them a unique position in Europe’s life sciences ecosystem. Through its deep ties to industry leaders and a robust scientific advisory board, Medicxi continues to drive the next generation of breakthrough therapeutics​.

Medingenii Capital, based in Houston, Texas, is a venture capital firm specializing in early-stage investments in healthcare, medical devices, healthtech, and life sciences. With a clear focus on disruptive solutions addressing critical challenges in these fields, the firm leverages its deep connections within the Texas Medical Center ecosystem and a global network of co-investors and industry leaders to scale startups for growth and successful exits. Notable portfolio companies include Vitls, Ucardia, and Forest Devices, all of which innovate in life sciences and medical technology. Medingenii’s investment strategy targets healthtech startups, particularly those advancing genomic testing, patient engagement, and medical devices. The firm prefers to engage early, often leading or co-investing in rounds. Their average check size typically hovers around $1.5M. The leadership team, including key figures like Greg Campbell, Diane Yoo, and Eddie Patton, brings decades of entrepreneurial and investment expertise, with a strong emphasis on supporting underrepresented founders and female-led ventures. Medingenii’s unique blend of healthcare specialization and its commitment to diversity position it as a critical player for startups seeking to make a significant impact in the medical and health sectors.

Manifold Ventures (MMV) is a venture capital firm focused on supporting early-stage companies in healthcare innovation. Founded by physicians and healthcare entrepreneurs, MMV invests in startups that are developing groundbreaking medical technologies and solutions. The firm is known for its hands-on approach, offering more than just capital; they provide strategic guidance, operational expertise, and access to an extensive network of industry professionals. Their portfolio includes companies like Stellation (patient-provider matching technology), PocketRN (telehealth nursing), and Gradient Health (a healthcare data marketplace). MMV's team, led by Dr. Branden Rosenhan and Dr. Saumitra Thakur, brings deep experience in both clinical practice and business, which they leverage to help their portfolio companies navigate the complexities of the healthcare industry. MMV is headquartered in Salt Lake City and focuses on identifying promising healthcare innovations early in their development cycle, with the goal of helping these startups scale into successful enterprises.

MedVenture Partners, Inc., a Tokyo-based venture capital firm, specializes in early-stage investments within the life sciences sector, with a distinct focus on medical devices and healthcare technologies. Established in 2013 by Hajime Oshita and Dr. Fumiaki Ikeno, the firm has rapidly built a reputation for identifying and nurturing innovative startups poised to disrupt the healthcare landscape. Their portfolio includes standout companies such as Biomedical Solutions, Inc., which exemplifies their commitment to fostering groundbreaking technologies. MedVenture’s investment strategy is characterized by a hands-on approach, often leading funding rounds and providing substantial guidance to portfolio companies. They prioritize startups that demonstrate strong potential for global impact, particularly those addressing critical medical needs. Their geographic focus remains largely on Japan, but they have shown interest in companies that can expand internationally. With over 22 billion Yen in assets under management, MedVenture manages multiple funds, the most recent of which raised 99 billion Yen. The firm’s approach to investment is strategic and collaborative, leveraging deep medical expertise alongside innovative technology. Startups seeking investment should be prepared to present compelling, well-researched pitches that highlight their innovation and market potential. Led by a team of seasoned professionals, including Oshita, who has over two decades of experience in the medical device industry, MedVenture Partners is committed to driving successful exits and significant market advances. Their active involvement in the growth and development of their portfolio companies underscores their role as a key player in Japan’s venture capital landscape.

Menlo Ventures, a Silicon Valley-based venture capital firm, has a robust history of investing in transformative technology companies across consumer, enterprise, and healthcare sectors. Notable investments include Uber, Roku, Warby Parker, Poshmark, and Chime. The firm focuses on early-stage investments but supports companies through their entire growth journey. Menlo Ventures recently closed a $1.35 billion fund aimed at backing the next generation of AI startups, reflecting its commitment to cutting-edge technologies. The firm also emphasizes deep involvement with portfolio companies, offering strategic guidance and support through every stage of development.

Merantix is a Berlin-based AI venture studio that has been building and investing in AI-driven startups since 2016. It operates Europe's largest AI platform, focusing on ideating, incubating, and scaling AI ventures across various industries. The company is notable for its emphasis on transformative AI applications, particularly in B2B sectors. Merantix has recently launched a €100 million fund, which is divided into three parts: €25 million for co-investing in external startups, €25 million for incubating new ventures, and €50 million for supporting existing investments. This marks a significant expansion from its traditional model, where it primarily incubated its own startups with an initial €1 million investment in exchange for equity. The firm has incubated successful companies like Vara, an AI breast cancer detection startup, and Cambrium, which focuses on AI-powered protein design. Merantix also hosts the AI Campus in Berlin, a 5,200 sqm co-working and community space dedicated to AI innovation, bringing together startups, corporations, and investors to foster collaboration. Merantix’s investment strategy focuses on early-stage companies, particularly in pre-seed and Series A rounds, with a strong emphasis on supporting founders who have deep domain expertise and a passion for AI.

Mercia Asset Management is a leading UK-based specialist asset manager that focuses on providing capital across four core asset classes: venture capital, private equity, debt, and balance sheet investments. Established initially as a seed capital provider linked to universities, it has grown to manage over £1.4 billion in assets, emphasizing support for small and medium enterprises (SMEs) across the UK, especially in underserved regional markets. The firm’s investment approach is built around its "Complete Connected Capital" model, which combines funds under management (FuM) with direct investments from its balance sheet. This hybrid strategy allows Mercia to offer flexible, long-term capital to startups and scale-ups, typically investing up to £10 million per round. Mercia's extensive portfolio covers sectors such as technology, healthcare, and advanced manufacturing, with notable investments in companies like Oxford Genetics and Netacea. Mercia operates nine regional offices, helping it maintain a close connection with local businesses, and collaborates with government bodies, institutional investors, and private individuals. The firm’s effective management of EIS (Enterprise Investment Scheme) and VCT (Venture Capital Trust) funds has enabled it to deliver consistent returns, achieving an average premium of around 53% on exits. Since its IPO in 2014, Mercia has demonstrated a solid track record in supporting the growth of UK regional businesses while delivering dividends to its investors, underpinning its strategy to be the top regional capital provider in the UK.

Mercia Asset Management, based in the UK, is a leading provider of venture, private equity, and debt financing, with a strong regional focus outside London. With over £1.5 billion in assets under management, Mercia actively backs early-stage businesses in sectors like AI, digital health, clean tech, and biosciences. Notable investments include Netacea (cybersecurity) and Nova Pangaea (sustainable aviation fuel), reflecting its commitment to high-growth sectors. Mercia typically invests between £500k to £20m, supporting startups through multiple stages of growth, including Seed to Series B. The firm’s focus on regional UK businesses helps address funding gaps, with 77% of their recent investments outside London. Their strategy prioritizes long-term partnerships with founders, often maintaining investments for five to seven years. The team, led by CEO Dr. Mark Payton, has a track record of successful exits, including the £100m sale of Faradion and the sale of nDreams to Aonic. Mercia's portfolio also benefits from its affiliation with major initiatives like the Northern Powerhouse Investment Fund, which helps accelerate regional growth. Mercia is known for being approachable and hands-on, offering mentorship alongside capital​.

Mercury Fund is an early-stage venture capital firm based in the U.S. that focuses on software startups, primarily in Middle America. Founded with the mission of driving innovation outside of coastal tech hubs, Mercury has built a portfolio that spans sectors such as SaaS, AI, and fintech. The firm has helped create over $9 billion in value by supporting transformative businesses, particularly in areas like enterprise SaaS, industrial IoT, and tech-enabled services. Mercury typically invests between $1 million and $4 million in Seed and Series A rounds, while also providing follow-on funding of up to $8 million over the life of a company. They act as lead or co-lead investors, helping startups achieve sustainable growth through their proprietary operational framework, which focuses on improving business processes early in a company's development. Notable companies in their portfolio include Cart.com, Benson Hill, and Amify. The firm takes pride in backing both first-time founders and seasoned entrepreneurs, offering them access to a vast network of growth partners and resources.